Vitamin D3 Analogues Manufacturer & Exporter
Premium vitamin D3 analogues for calcium regulation and specialized therapies
| Product Name | Pharmacopoeia | CAS No. | Therapeutic Application | DMF Status |
|---|---|---|---|---|
| Alfacalcidol | IP/EP/BP | 41294-56-8 | Calcium Regulator | ODMF |
| Calcipotriol Anhydrous | BP/EP/IP | 112965-21-6 | Anti-Psoriasis | Teck Pack |
| Calcipotriol Monohydrate | BP/EP | 147657-22-5 | Anti-Psoriasis | CEP (EDQM), ODMF |
| Calcitriol | BP/EP/IP/USP | 32222-06-3 | Calcium Regulator | Ethiopia, Tanzania |
FAQ's
1. What Vitamin D3 analogues does DK Pharmachem manufacture?
DK Pharmachem manufactures Alfacalcidol (CAS 41294-56-8), Calcipotriol Anhydrous (CAS 112965-21-6), Calcipotriol Monohydrate (CAS 147657-22-5), and Calcitriol (CAS 32222-06-3), covering calcium regulator and anti-psoriasis therapeutic applications.
2. What pharmacopoeia grades are available for Vitamin D3 analogues?
Products are manufactured to IP, EP, BP, and USP pharmacopoeia standards depending on the compound, with Calcitriol available across all four (BP/EP/IP/USP) and the Calcipotriol variants covering BP/EP/IP.
3. What is the DMF status of DK Pharmachem's Vitamin D3 analogues?
Alfacalcidol carries an Open DMF (ODMF), Calcipotriol Anhydrous is available with Tech Pack documentation, and Calcipotriol Monohydrate holds both a CEP (EDQM) and ODMF. Calcitriol is currently registered for Ethiopia and Tanzania. Contact the DK Pharmachem team for current documentation status by destination market.
4. What is the difference between Calcipotriol Anhydrous and Calcipotriol Monohydrate?
Both are anti-psoriasis actives under the Vitamin D3 analogue class, differing in their crystalline/hydrate form (anhydrous vs. monohydrate), which affects formulation compatibility. DK Pharmachem supplies both forms with the documentation package (Tech Pack or CEP/ODMF) relevant to each.
5. Which therapeutic applications do these Vitamin D3 analogues serve?
Alfacalcidol and Calcitriol are used as calcium regulators, while Calcipotriol Anhydrous and Calcipotriol Monohydrate are used in anti-psoriasis formulations.
6. What documentation is provided with each Vitamin D3 analogue shipment?
Each shipment includes a Certificate of Analysis (CoA) confirming compliance with the relevant pharmacopoeia specification, along with regulatory documentation (DMF, CEP, or Tech Pack) applicable to the buyer’s destination market.
7. Does DK Pharmachem support new market registrations for Vitamin D3 analogues?
Yes. With existing registrations in markets like Ethiopia and Tanzania for Calcitriol, and ODMF/CEP filings for other analogues, DK Pharmachem supports regulatory filings and documentation requirements for new market entry on request.
8. What is the minimum order quantity (MOQ) for Vitamin D3 analogues?
MOQ depends on the specific analogue, its DMF/CEP documentation status, and batch size. Share the product name and required quantity with the DK Pharmachem team for a tailored quote.
Product Categories
Explore our comprehensive range of pharmaceutical ingredients and speciality Chemicals
APIs Active Pharmaceutical
Ingredients
Ingredients
Comprehensive range of high- quality APIs for global pharmaceutical manufacturing
Vitamin D3 Analogues Specialized Vitamin D3 Products
Premium vitamin D3 analogues for calcium regulation and specialized therapies
New / Pipeline Products Innovation Pipeline
Emerging products and innovative solutions for future pharmaceutical needs
IntermediatesChemical Intermediates
High-purity intermediates for pharmaceutical synthesis and manufacturing
Specialty Fine ChemicalsSpecialized Chemical Solutions
Custom specialty chemicals for diverse pharmaceutical applications